halothane and chlorocresol

halothane has been researched along with chlorocresol in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (23.08)	18.2507
2000's	7 (53.85)	29.6817
2010's	3 (23.08)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bittner, RE; Fricker, R; Gilly, H; Kress, HG; Musat, I; Steinbereithner, K	1
Adnet, PJ; Ben-Abraham, R; Haudcoeur, G; Krivosic-Horber, RM; Perel, A	1
Bendixen, D; Fagerlund, T; Gardi, T; Glahn, K; Ording, H	1
Allen, PD; López, JR	1
Bina, S; Brandom, BW; Daly, JW; Gallagher, KL; Holman, SJ; Hosoi, E; Muldoon, S; Pudimat, PA; Sei, Y; Venzon, DJ; Wyre, HW	1
Anetseder, M; Baur, CP; Censier, K; Doetsch, S; Felleiter, P; Fiege, M; Fricker, R; Halsall, PJ; Hartung, E; Heffron, JJ; Heytens, L; Hopkins, PM; Klingler, W; Lehmann-Horn, F; Nivoche, Y; Schulte am Esch, J; Tegazzin, V; Tzanova, I; Urwyler, A; Wappler, F; Weisshorn, R	1
Koenig, F; Olthoff, D; Rueffert, H; Wehner, M	2
Bina, S; Bünger, R; Cowan, G; Karaian, J; Mongan, P; Muldoon, S	1
Kaufmann, A; Kraft, B; Michalek-Sauberer, A; Weigl, LG	1
Hamada, H; Kawamoto, M; Kobayashi, M; Migita, T; Mukaida, K; Yuge, O	1
Bina, S; Bünger, R; Capacchione, J; Muldoon, S; Munkhuu, B	1
Johannsen, S; Mögele, S; Müller, CR; Roewer, N; Schneiderbanger, D; Schuster, F; Treves, S	1

Trials

1 trial(s) available for halothane and chlorocresol

Article	Year
Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility. European journal of anaesthesiology, 2003, Volume: 20, Issue:7 Topics: Biopsy; Caffeine; Cresols; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Muscle, Skeletal; Sensitivity and Specificity	2003

Article

Year

Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility.

European journal of anaesthesiology, 2003, Volume: 20, Issue:7

Topics: Biopsy; Caffeine; Cresols; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Muscle, Skeletal; Sensitivity and Specificity

2003

Other Studies

12 other study(ies) available for halothane and chlorocresol

Article	Year
Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol. Anesthesia and analgesia, 1997, Volume: 85, Issue:1 Topics: Adolescent; Adult; Aged; Anesthetics, Inhalation; Caffeine; Cresols; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Halothane; Humans; In Vitro Techniques; Male; Malignant Hyperthermia; Middle Aged; Muscle Contraction; Muscle, Skeletal; Sensitivity and Specificity	1997
[Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients]. Harefuah, 1997, Jun-15, Volume: 132, Issue:12 Topics: Adolescent; Adult; Caffeine; Cresols; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Middle Aged; Muscle Contraction; Muscle Fibers, Skeletal; Muscle, Skeletal; Phenotype	1997
4-Chloro-m-cresol test--a possible supplementary test for diagnosis of malignant hyperthermia susceptibility. Acta anaesthesiologica Scandinavica, 1997, Volume: 41, Issue:8 Topics: Biopsy; Caffeine; Cresols; Disease Susceptibility; Dose-Response Relationship, Drug; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Ryanodine	1997
"Noninvasive" testing for malignant hyperthermia susceptibility. Anesthesiology, 2002, Volume: 97, Issue:5 Topics: Caffeine; Calcium; Cresols; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia; Muscle Contraction	2002
Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes. Anesthesiology, 2002, Volume: 97, Issue:5 Topics: Adolescent; Adult; B-Lymphocytes; Caffeine; Calcium; Child; Cresols; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia; Middle Aged; Muscle Contraction; Mutation; Ryanodine Receptor Calcium Release Channel	2002
Calcium release from sarcoplasmic reticulum is facilitated in human myotubes derived from carriers of the ryanodine receptor type 1 mutations Ile2182Phe and Gly2375Ala. Genetic testing, 2003,Fall, Volume: 7, Issue:3 Topics: Adult; Aged; Caffeine; Calcium; Child; Child, Preschool; Cresols; Female; Genetic Predisposition to Disease; Halothane; Heterozygote; Humans; Male; Malignant Hyperthermia; Middle Aged; Muscle Contraction; Muscle Fibers, Skeletal; Point Mutation; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum	2003
Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model. Neuromuscular disorders : NMD, 2004, Volume: 14, Issue:7 Topics: Adolescent; Adult; Aged; Anesthetics; Biopsy; Caffeine; Calcium; Cells, Cultured; Central Nervous System Stimulants; Child; Child, Preschool; Cresols; Dose-Response Relationship, Drug; Exons; Family Health; Fungicides, Industrial; Fura-2; Halothane; Humans; In Vitro Techniques; Male; Malignant Hyperthermia; Middle Aged; Molecular Biology; Muscle Contraction; Muscle Fibers, Skeletal; Muscle, Skeletal; Mutation; Ryanodine Receptor Calcium Release Channel	2004
Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis. Anesthesiology, 2006, Volume: 104, Issue:1 Topics: Anesthesia, General; Anesthetics, Dissociative; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Blood Gas Analysis; Caffeine; Central Nervous System Stimulants; Creatine Kinase; Cresols; Dose-Response Relationship, Drug; Electrolytes; Glucose; Halothane; Ketamine; Lactic Acid; Malignant Hyperthermia; Microdialysis; Muscle, Skeletal; Propofol; Pyruvic Acid; Ryanodine Receptor Calcium Release Channel; Swine	2006
Novel ryanodine receptor mutation that may cause malignant hyperthermia. Anesthesiology, 2008, Volume: 109, Issue:3 Topics: Amino Acid Substitution; Anesthetics, Inhalation; Austria; Caffeine; Calcium; Cells, Cultured; Central Nervous System Stimulants; Child; Cresols; Dose-Response Relationship, Drug; Female; Halothane; Humans; Male; Malignant Hyperthermia; Muscle Contraction; Muscle Fibers, Skeletal; Muscle, Skeletal; Mutation; Patch-Clamp Techniques; Polymerase Chain Reaction; RNA, Messenger; Ryanodine Receptor Calcium Release Channel	2008
Analysis of human cultured myotubes responses mediated by ryanodine receptor 1. Anaesthesia and intensive care, 2011, Volume: 39, Issue:2 Topics: Adolescent; Adult; Aged; Caffeine; Calcium; Cells, Cultured; Child; Child, Preschool; Cresols; Dose-Response Relationship, Drug; Female; Genetic Predisposition to Disease; Halothane; Humans; Male; Malignant Hyperthermia; Middle Aged; Muscle Fibers, Skeletal; ROC Curve; Ryanodine Receptor Calcium Release Channel; Young Adult	2011
Is lymphocyte adenosine a diagnostic marker of clinical malignant hyperthermia? A pilot study. Critical care medicine, 2015, Volume: 43, Issue:3 Topics: Adenosine; Anesthetics, Inhalation; Biomarkers; Calcium; Cresols; Female; Halothane; Humans; Lymphocytes; Male; Malignant Hyperthermia; Muscle, Skeletal; Phenotype; Pilot Projects; ROC Curve; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum	2015
Functional characterization of the RYR1 mutation p.Arg4737Trp associated with susceptibility to malignant hyperthermia. Neuromuscular disorders : NMD, 2016, Volume: 26, Issue:1 Topics: Anesthetics; Arginine; B-Lymphocytes; Caffeine; Cell Line, Transformed; Cresols; Family Health; Female; Fungicides, Industrial; Genetic Predisposition to Disease; Germany; Halothane; Humans; Male; Malignant Hyperthermia; Muscle Contraction; Muscle, Skeletal; Phosphodiesterase Inhibitors; Polymorphism, Single Nucleotide; Ryanodine Receptor Calcium Release Channel; Tryptophan	2016